Advertisement

Topics

Sinovac Biotech Ltd. Company Profile

19:27 EST 13th November 2018 | BioPortfolio

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). PanfluTM, Sinovac's pandemic influenza vaccine (H5N1), has already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines. Its 30%-owned joint venture, Sinovac Dalian, focuses on the research, development, manufacturing and commercialization of vaccines, such as rabies, chickenpox, mumps and rubella vaccines for human use.


News Articles [1674 Associated News Articles listed on BioPortfolio]

Sinovac Biotech Says SEC Concludes Investigation

BEIJING (dpa-AFX) - Sinovac Biotech Ltd. (SVA), a provider of biopharmaceutical products in China, said that the U.S. Securities and Exchange Commission or SEC has concluded its investigation into...

Mutiny at Sinovac now likely to delay vaccine launch

An attempted coup is proving costly at Sinovac Biotech, a Chinese vaccines developer.

Sinovac Raises $86.7 Million, Scraps Privatization

Sinovac Biotech, a Beijing vaccine maker, completed an $86.7 million private placement from two China-focused healthcare investors, Vivo Capital and Advantech Capital. For two years, Sinovac has been ...

Mumps Pipeline Review, H2 2018 Featuring Cadila Healthcare Ltd, GlaxoSmithKline Plc & Sinovac Biotech Ltd – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Mumps – Pipeline Review, H2 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. Mumps – Pipeline Review, H2 ...

Sinovac Commences Legal Proceedings to Nullify Filings Bearing a Falsified Company Seal and Forged Board Member Signatures

Senior management of Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company") and the lawful directors of Sinovac Hong Kong have commenced leg...

SEC Concludes Investigation of Sinovac

BEIJING, Aug. 20, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced t...

5 Top Weekly NASDAQ Biotech Stocks: Correvio Lands on Top

Correvio Pharma, BioLife Solutions, XBiotech, Sinovac Biotech and La Jolla Pharma were last week's top gainers on the NASDAQ Biotechnology Index. The post 5 Top Weekly NASDAQ Biotech Stocks: Correvio...

DOJ Closes Investigation of Sinovac

BEIJING, Sept. 17, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced ...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

Clinical Trials [19 Associated Clinical Trials listed on BioPortfolio]

Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military

The purpose of this study is to assess the safety and immunogenicity of three seasonal trivalent influenza vaccines (TIVs)manufactured by Glaxosmith Kline (GSK), Beijing Sinovac Biotech (S...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants

A single center, observer-masked, randomized clinical trial is to be conducted in 6-35 months infants to evaluate the safety and immunogenicity of Sinovac's influenza A/H1N1 Vaccine (PANF...

Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults

A single center, randomized clinical trial is to be conducted in healthy adults (18-60 years) to evaluate the safety and immunogenicity and study the cell-mediated Immunity of Sinovac's H1...

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Companies [922 Associated Companies listed on BioPortfolio]

Sinovac Biotech

Sinovac Biotech Ltd. (also known in China as Beijing Kexing Bioproducts) specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepat...

Sinovac Biotech, Ltd.

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious disea...

Sinovac Biotech Ltd.

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious disea...

Sinovac Biotech Ltd.

Sinovac Biotech Ltd. is a China-based biopharmaceutical Company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against hum...

Sinovac Biotech Co., Ltd.

More Information about "Sinovac Biotech Ltd." on BioPortfolio

We have published hundreds of Sinovac Biotech Ltd. news stories on BioPortfolio along with dozens of Sinovac Biotech Ltd. Clinical Trials and PubMed Articles about Sinovac Biotech Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sinovac Biotech Ltd. Companies in our database. You can also find out about relevant Sinovac Biotech Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record